Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Mechanism Biomarkers Predict Diagnosis in Schizophrenia and Schizoaffective Psychosis, with Implications for Treatment.

International journal of molecular sciences - 31 Oct 2023

Fryar-Williams Stephanie, Tucker Graeme, Strobel Jörg, Huang Yichao, Clements Peter

Abstract excerpt

Diagnostic uncertainty and relapse rates in schizophrenia and schizoaffective disorder are relatively high, indicating the potential involvement of other pathological mechanisms that could serve as diagnostic indicators to be targeted for adjunctive treatment. This study aimed to seek objective evidence of methylenetetrahydrofolate reductase MTHFR C677T genotype-related bio markers in blood and urine. Vitamin and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Catecholamines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Folic Acid

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Psychotic Disorders

Share to Riboflavin

Share to Schizophrenia

Share to Vitamins

Source

Open in PubMed Open full text

Identifiers

PMID: 37958826
DOI: 10.3390/ijms242115845
PMCID: PMC10650772

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Mechanism Biomarkers Predict Diagnosis in Schizophrenia and Schizoaffective Psychosis, with Implications for Treatment.PMID 37958826Read ↗

Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis.Semantic proximity Read ↗

Fundamental Role of Methylenetetrahydrofolate Reductase 677 C → T Genotype and Flavin Compounds in Biochemical Phenotypes for Schizophrenia and Schizoaffective PsychosisSemantic proximity Read ↗

Gene Variant Related Neurological and Molecular Biomarkers Predict Psychosis Progression, with Potential for Monitoring and Prevention.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase and psychiatric diseasesSemantic proximity Read ↗

Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity Read ↗

MTHFD1 1958 G>A Genetic Polymorphism (rs2236225) Dichotomy in Schizophrenia: Lower Manifestation Risks, but More Severe Negative SymptomsSemantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

The general neurocognitive decline in patients with methamphetamine (MA) use and transient MA-induced psychosis is primarily determined by oxidative and AGE-RAGE stressSemantic proximity Read ↗

Evidence-based umbrella review of 162 peripheral biomarkers for major mental disordersSemantic proximity Read ↗

Efficient Prediction of Vitamin B Deficiencies via Machine-learning Using Routine Blood Test Results in Patients With Intense Psychiatric EpisodeSemantic proximity Read ↗

Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis.Semantic proximity Read ↗

Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.